In summary, eliminating C5ar1 in the Arctic AD model results in a decrease or delay of expression of many, but not all, reactive glial genes associated with AD in human or mouse models, indicating a separation between those genes induced by amyloid plaques (or other sources of “damage”) and those requiring the C5a–C5aR1 signaling. Here, C5 is linked to Alzheimer disease.